Nifty
:
16992.55
Sensex
:
57720.37
47.50 (0.28%)
193.27 (0.34%)
Nifty
Sensex
:
:
16992.55
57720.37
47.50 (0.28%)
193.27 (0.34%)

Jubilant Pharmova Ltd.

Chemicals

Rating :
35/99

BSE: 530019 | NSE: JUBLPHARMA

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,482.97
  • 46.50
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,426.35
  • 1.78%
  • 0.82

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 2.71%
  • 18.68%
  • FII
  • DII
  • Others
  • 23.38%
  • 0.40%
  • 4.15%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.73
  • -4.00
  • -12.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.80
  • -5.30
  • -9.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.75
  • -7.99
  • -22.14

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.06
  • 14.35
  • 14.03

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.12
  • 1.87
  • 1.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.66
  • 7.78
  • 7.74

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
1,552.51
1,310.53
18.46%
1,599.50
1,657.45
-3.50%
1,451.72
1,634.65
-11.19%
1,527.53
1,579.78
-3.31%
Expenses
1,406.63
1,116.29
26.01%
1,380.75
1,317.95
4.76%
1,259.32
1,259.41
-0.01%
1,280.18
1,205.16
6.22%
EBITDA
145.88
194.24
-24.90%
218.75
339.50
-35.57%
192.40
375.24
-48.73%
247.35
374.62
-33.97%
EBIDTM
9.40%
14.82%
13.68%
20.48%
13.25%
22.96%
16.19%
23.71%
Other Income
9.47
5.91
60.24%
13.10
4.45
194.38%
11.31
3.89
190.75%
-2.96
6.69
-
Interest
50.69
36.62
38.42%
42.02
34.74
20.96%
39.93
34.62
15.34%
39.51
43.34
-8.84%
Depreciation
94.28
93.33
1.02%
93.95
99.78
-5.84%
94.57
88.04
7.42%
100.55
86.24
16.59%
PBT
10.38
70.20
-85.21%
39.06
209.43
-81.35%
69.21
256.47
-73.01%
104.33
241.39
-56.78%
Tax
24.77
19.43
27.48%
31.48
65.40
-51.87%
22.31
86.02
-74.06%
46.58
83.06
-43.92%
PAT
-14.39
50.77
-
7.58
144.03
-94.74%
46.90
170.45
-72.48%
57.75
158.33
-63.53%
PATM
-0.93%
3.87%
0.47%
8.69%
3.23%
10.43%
3.78%
10.02%
EPS
-0.98
3.20
-
0.34
8.97
-96.21%
2.95
10.09
-70.76%
3.74
13.44
-72.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
6,131.26
6,130.16
6,098.53
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
Net Sales Growth
-0.83%
0.52%
-33.38%
0.48%
21.19%
28.26%
1.95%
-1.32%
0.39%
12.34%
 
Cost Of Goods Sold
1,762.92
1,488.01
1,536.01
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
Gross Profit
4,368.34
4,642.16
4,562.52
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
GP Margin
71.25%
75.73%
74.81%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
Total Expenditure
5,326.88
4,973.83
4,702.07
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
Power & Fuel Cost
-
134.30
105.79
112.21
466.38
424.91
333.66
366.71
393.04
389.74
356.73
% Of Sales
-
2.19%
1.73%
1.23%
5.12%
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
Employee Cost
-
2,043.39
1,922.88
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
% Of Sales
-
33.33%
31.53%
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
Manufacturing Exp.
-
562.32
449.40
362.15
552.26
485.98
428.84
436.46
432.40
405.14
360.48
% Of Sales
-
9.17%
7.37%
3.96%
6.06%
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
General & Admin Exp.
-
432.34
387.92
416.80
540.75
354.56
280.98
256.23
302.28
264.23
208.35
% Of Sales
-
7.05%
6.36%
4.55%
5.94%
4.72%
4.79%
4.46%
5.19%
4.55%
4.03%
Selling & Distn. Exp.
-
209.71
177.15
194.71
267.70
247.85
185.79
135.54
203.98
160.04
123.28
% Of Sales
-
3.42%
2.90%
2.13%
2.94%
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
Miscellaneous Exp.
-
103.77
122.93
853.22
96.92
67.76
53.20
65.96
39.72
19.59
123.28
% Of Sales
-
1.69%
2.02%
9.32%
1.06%
0.90%
0.91%
1.15%
0.68%
0.34%
0.46%
EBITDA
804.38
1,156.33
1,396.46
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
EBITDA Margin
13.12%
18.86%
22.90%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
Other Income
30.92
11.29
17.64
47.43
35.74
40.03
24.86
13.37
42.45
19.06
29.87
Interest
172.15
145.49
184.10
287.41
219.81
284.28
341.11
371.35
367.61
337.11
310.93
Depreciation
383.35
381.70
348.95
461.93
370.90
415.05
291.40
346.74
287.95
281.17
253.79
PBT
222.98
640.43
881.05
1,245.17
1,184.04
859.08
737.64
542.22
88.43
421.78
533.29
Tax
125.14
217.43
297.22
312.29
326.80
224.66
163.02
155.40
80.48
69.64
152.36
Tax Rate
56.12%
33.95%
34.57%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
PAT
97.84
423.92
562.87
898.24
574.46
642.81
575.66
391.83
-57.76
109.04
152.73
PAT before Minority Interest
99.53
423.00
562.61
898.24
577.01
634.42
574.63
386.82
-40.16
137.64
188.78
Minority Interest
1.69
0.92
0.26
0.00
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
PAT Margin
1.60%
6.92%
9.23%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
PAT Growth
-81.31%
-24.69%
-37.34%
56.36%
-10.63%
11.66%
46.92%
-
-
-28.61%
 
EPS
6.14
26.61
35.33
56.39
36.06
40.35
36.14
24.60
-3.63
6.84
9.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
5,318.56
4,741.49
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
Share Capital
15.92
15.92
15.93
15.93
15.58
15.57
15.54
15.93
15.45
15.93
Total Reserves
5,298.98
4,724.75
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
Non-Current Liabilities
2,921.59
2,973.05
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
Secured Loans
200.94
20.78
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
Unsecured Loans
2,263.30
2,543.19
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
0.22
760.06
Long Term Provisions
95.67
94.01
150.75
114.35
107.08
80.69
70.31
67.04
219.53
237.96
Current Liabilities
1,591.60
1,048.83
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
Trade Payables
567.74
520.48
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
718.14
647.13
Other Current Liabilities
838.52
371.73
674.21
473.57
505.87
572.70
951.43
793.31
1,731.20
898.00
Short Term Borrowings
64.00
20.00
649.89
499.71
244.85
255.60
748.97
517.17
1,187.83
1,131.39
Short Term Provisions
121.34
136.62
204.64
96.31
117.81
106.24
151.93
97.49
257.25
101.84
Total Liabilities
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
Net Block
4,870.61
4,608.75
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
Gross Block
6,691.97
6,089.57
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
Accumulated Depreciation
1,821.36
1,480.83
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
Non Current Assets
6,320.40
5,810.90
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
Capital Work in Progress
1,089.57
896.99
768.39
901.43
670.97
683.78
611.32
596.60
472.39
436.89
Non Current Investment
238.60
240.96
69.36
115.11
123.52
102.71
85.43
39.50
33.99
25.61
Long Term Loans & Adv.
117.64
62.84
86.81
68.59
71.79
56.32
62.67
327.17
328.42
379.47
Other Non Current Assets
3.98
1.35
7.53
0.66
0.58
1.08
0.53
29.68
2.21
0.37
Current Assets
3,509.19
2,952.50
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,254.87
1,129.38
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
Sundry Debtors
927.99
819.90
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
805.87
708.54
Cash & Bank
984.24
671.32
1,399.87
1,370.41
248.79
459.63
344.58
394.34
479.53
356.05
Other Current Assets
342.09
242.37
419.59
485.64
418.81
262.79
377.13
265.59
301.21
380.29
Short Term Loans & Adv.
100.53
89.53
80.29
39.80
45.75
37.06
133.06
144.56
136.04
182.01
Net Current Assets
1,917.59
1,903.67
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
Total Assets
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
837.54
1,784.27
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
PBT
630.45
1,212.01
1,210.53
903.81
859.08
737.64
542.22
40.32
207.28
341.14
Adjustment
579.47
716.48
760.74
861.53
687.81
637.90
737.89
725.84
756.60
752.36
Changes in Working Capital
-178.29
249.90
-179.67
-300.53
14.15
36.88
-133.16
96.40
-110.70
-4.04
Cash after chg. in Working capital
1,031.63
2,178.39
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-194.09
-394.12
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-380.37
-739.01
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
Net Fixed Assets
0.99
2,198.22
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
Net Investments
0.23
118.05
-0.14
-57.59
3.34
-0.39
57.01
239.81
-27.56
-18.79
Others
-381.59
-3,055.28
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
Cash from Financing Activity
-32.60
-1,709.39
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
Net Cash Inflow / Outflow
424.57
-664.13
165.56
767.10
-215.63
132.22
-56.38
-62.76
183.44
20.41
Opening Cash & Equivalents
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.64
473.49
279.65
263.08
Closing Cash & Equivalent
983.82
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.63
473.49
279.65

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
333.91
297.84
351.83
301.93
262.33
220.61
190.90
154.04
170.07
155.46
ROA
4.55%
5.34%
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
ROE
8.41%
10.88%
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
ROCE
10.09%
11.89%
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
Fixed Asset Turnover
0.96
0.87
1.23
1.38
1.26
1.09
0.92
0.81
0.84
0.82
Receivable days
52.04
63.24
51.13
48.12
51.58
59.43
54.81
49.56
46.53
47.00
Inventory Days
70.98
89.02
65.05
56.26
63.07
73.64
75.51
78.58
75.51
73.76
Payable days
133.47
191.38
58.75
55.42
56.86
54.84
53.44
52.17
51.42
45.33
Cash Conversion Cycle
-10.45
-39.12
57.43
48.96
57.79
78.23
76.88
75.98
70.61
75.42
Total Debt/Equity
0.55
0.55
0.83
1.01
0.85
1.18
1.51
1.95
1.67
1.71
Interest Cover
5.40
5.67
5.21
5.11
4.02
3.16
2.46
1.11
1.61
2.10

Annual Reports:

FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013

News Update:


  • Jubilant Pharmova’s arm gets additional loan facility from Government of Canada
    17th Mar 2023, 16:49 PM

    This expansion project is aimed at upgrading the company's Montreal facility

    Read More
  • USFDA classifies Jubilant Pharmova’s API Facility as VAI
    8th Mar 2023, 15:58 PM

    USFDA had inspected its API manufacturing facility at Nanjangud during December 05, 2022 to December 13, 2022

    Read More
  • Jubilant Pharmova - Quarterly Results
    3rd Feb 2023, 13:03 PM

    Read More
  • Jubilant Pharmova’s arm receives USFDA’s approval for Technetium Mertiatide Injection
    1st Feb 2023, 09:47 AM

    This approval is effective from January 30, 2023

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.